The routes of 14C excretion following the administration of a single oral 230 mg/kg body weight dose of 2-ethoxyethanol [ethanol-1,2-'4C] or 2-ethoxyethanol [ethoxy-1-'4C] to male Sprague-Dawley rats were investigated. Elimination of the '4C by the urinary route accounted for 76 to 80% of the dose within 96 hr.
No chronic health effects resulting from industrial use of 2-ethoxyethanol have been reported. However, effects of 2-ethoxyethanol in animals include tubular degeneration in the kidney (2) , erythrocyte hemolysis (3, 4) , and reduced leukocyte count (5) . More recently, Nelson et al. (6) showed neurochemical and behavioral changes in the offspring of female rats exposed to 2-ethoxyethanol. Although no adverse reproductive effects resulting from human exposure to 2-ethoxyethanol have been reported, testicular damage in rats exposed to the chemical was described as early as 1942 . In that year, Morris et al. (7) showed that rats developed tubular atrophy and edema of the testes after the oral administration of 2-ethoxyethanol. Similar effects have also been noted in mice (5, 8) . Miller and his co-workers have demonstrated that 2-methoxyethanol, a closely related glycol ether, causes degeneration of the germinal epithelium of the testes of rats (9) . Subsequently, Miller et al. (10) showed that a similar condition resulted from the administration of methoxyacetic acid, a metabolite of 2-methoxyethanol (11) . The metabolism of two other ethylene glycol monoalkyl ethers, n-butoxyethanol (12, 13) and isopropoxyethanol (14) , has been reported to proceed by oxidation to the corresponding carboxylic acid. Conjugation of isopropoxyethanol (14) and 2- ethoxyethanol (15) metabolites with glycine has been reported. In a previous study of the biotransformation of 2-ethoxyethanol in the rat, Jonsson et al. (15) identified ethoxyacetic acid and N-ethoxyacetyl glycine as urinary metabolites. These investigators, however, recovered only an estimated 30% ofthe administered dose.
The objectives of this study were to supplement the earlier work on the biotransformation of 2-ethoxyethanol in the rat by determining the fate of the compound following oral administration and to identify the chemical species associated with testicular damage.
Methods

Chemicals and Dosing Solutions
The test compound, 2-ethoxyethanol The dose range for the toxicity study was established by treating groups of two rats with various amounts of undiluted 2-ethoxyethanol. Upon initiation of the toxicity experiment, the rats were starved overnight, weighed (192.6 + 12.3), and randomly assigned to six groups of ten rats each. Doses of 250, 500, 1000, 2000, 4000, and 8000 mg/kg body weight were administered, by gavage, to all rats within the corresponding dosage groups. These animals were observed for mortality during the subsequent 14-day period. The LD50 value was calculated from the mortality in the several groups by the probit method of Finney (18) .
In subsequent excretion and metabolism studies, animals in the same weight range were transferred to individual Roth-type glass metabolism cages. Laboratory air, dried and freed of carbon dioxide, organics, and particulates, was passed through the metabolic chambers at a flow rate of 0.5 L/min. Except for an 18- Front and back sections of charcoal from sample collection tubes were combusted separately in the sample oxidizer. Carcasses were solubilized in 1 N NaOH prepared in 70% (v/v) aqueous methanol, and five portions of the digest were combusted. Cage washings were homogenized using a Polytron Model PCU-1 homogenizer equipped with a PC-10 probe (Kinematica Gmbh, Luzern, Switzerland), and five 0.5-mL aliquots were combusted. Carbon-14 was determined using a Model LS8100 liquid scintillation spectrometer (Beckman Instruments, Inc., Fullerton, CA), and data were corrected for background and quenching. Counting efficiency was calculated using an external standard.
Separation and Isolation of Metabolites
Urinary metabolites were separated by HPLC with a 50 cm x 9 mm internal diameter stainless steel column packed with Partisil-10 OD-2 (Whatman, Inc., Clifton, NJ). A model ALC/GPC 201 high-performance liquid chromatograph equipped with two Model 6000A pumps and a Model U6K injector (Waters Associates, Inc., Milford, MA) was used throughout the study. Solvent gradient conditions were controlled by a Model 720 system controller (Waters Associates, Inc.). Individual urine samples were thawed, adjusted to pH 3 with glacial acetic acid, and filtered through a 0.45-,um pore size disposable filter assembly (Acrodisk, Gelman Sciences, Ann Arbor, MI) prior to HPLC analysis. A portion of each of these samples was initially chromatographed for 20 min isocratically with 1% acetic acid in water. Metabolites were then eluted by using a methanol:1% acetic acid solvent system, linearly programmed from 15% to 80% methanol in 40 min. The solvent flow rate was maintained at 1 mL/min during the 60-min period of analysis. Radioactive metabolites were detected and quantified by using an in-line TriCarb RAM 7500 radioactivity monitor equipped with a quartz flow cell packed with a solid scintillator (Packard Instrument Co.).
Another portion of urine was acidified to pH 1 with 6 N HCl and heated at 90°C for 4 hr under nitrogen to hydrolyze possible conjugates. The urine was then adjusted to pH 3 with 6 N NaOH, filtered, and analyzed by HPLC.
Urinary metabolites were collected, pooled by retention time, and lyophilized using a Model 75035 freeze dryer (Labconco Corporation, Kansas City, MO). Residues were subsequently taken up in 1 mL of methanol for identification of metabolites by chromatographic techniques.
Testes were also examined for the presence of radioactive compounds by HPLC. Rat testes were thawed, minced, and homogenized in three volumes of distilled water using a Polytron Model PCU-1 homogenizer equipped with a PC-10 probe. Homogenates were lyophilized, and the residues were extracted three times with 1-mL volumes of methanol. These extracts were combined and concentrated to 1 mL for HPLC analysis using the same chromatographic conditions described previously. The single radioactive fraction was collected for further characterization by gas-liquid chromatography (GLC) and thin-layer chromatography (TLC). The two major urinary metabolites or their ethyl esters were further characterized by determination of boiling points at atmospheric or reduced pressure. In addition, mass spectra of the major urinary metabolite and the corresponding reference compound were obtained by using a Model 5982A mass spectrometer (Hewlett-Packard Co., Palo Alto, CA) operating with an electron energy of 70 eV A model 5711 gas chromatograph (Hewlett-Packard Co., Avondale, PA), fitted with a 91 cm x 2 mm glass column packed with 3% SP-2300 on 100/120-mesh Supelcoport (Supelco, Inc.), was interfaced to the mass spectrometer through a glass-jet separator. The oven temperature was programmed from 100 to 150°C at 2°C/min. A helium carrier gas flow rate of 30 cm3/min was used. All mass spectral data were acquired and processed using a Model 5834A data system (Hewlett-Packard Co.).
Characterization of Metabolites
Statistical Analysis
Statistical differences between groups were determined using Student's t-test. The biological half-times of the two radioisotopes were calculated by linear regression analysis.
Results
Determination of Acute Toxicity
The single-dose oral LD50 for 2-ethoxyethanol determined in 190 to 210 g male Sprague-Dawley rats, based upon 14-day mortality data, was determined to be 2300 mg/kg body weight. 
Excretion of Radioactivity
The principal route of excretion of the administered radioactivity was via the kidneys. Rats treated with the ethanol-labeled material excreted 80.6% of the dose in the 96-hr collection period. The corresponding value for rats treated with the ethoxy-labeled compound was 75.5% of the dose. When the amounts of 14C in the cage washes -considered to be residual urine -were added, the total urinary recoveries became 85.4% and 77.8% of the dose for the ethanol-labeled and ethoxy-labeled compounds, respectively. The elimination of radioactivity in the urine was rapid with 71.6% of the ethanollabel and 69.9% of the ethoxy-label excreted over the first 24 hr. Only an additional 6 to 9% of the administered radioactivity was excreted in the urine during the ensuing 72 hours (Fig. 1) . Administration of the ethoxylabeled compound resulted in the excretion of 11.7% of the dose as respiratory 14CO2. In contrast, the ethanollabeled compound gave rise to only 4.6% of the dose as 14CO2. After the first 10 hr, the output of labeled CO2 rapidly declined. By 30 hr, the expiration of 14CO2 had virtually ceased (Fig. 2) , and sampling was discontinued at that time. Only trace amounts of volatile organics were found in the breath of rats treated with either radiolabeled compound. Relatively minor amounts of 14C were excreted in the feces or remained in the carcass at 96 hr after treatment with either radiochemical. The biological half-times for the ethanoland ethoxy-labeled compounds were 12.5 + 1.9 hr and 9.9 + 1.5 hr, respectively. 
Metabolism of 2-Ethoxyethanol
The urinary metabolites excreted by rats following administration of either radiochemical were separated by HPLC and quantified by scintillation spectrometry. The relative amounts of each metabolite were calculated by summation of these analytical results for each urine sample collected over the 96-hr period (Table 2) . Of the 12 distinct radiolabeled components present in the urine of rats treated with either radiochemical, only two minor components were found not to be common metabolites of both. Urinary metabolite E, representing 1.4% of the administered 14C, was specific for the ethanol-labeled compound, whereas metabolite F, representing 1.5%, appeared only in the urine of rats treated with the ethoxy-labeled compound.
The two major metabolites together accounted for 73 to 76% of the administered radioactive dose. The more abundant of these, metabolite H, accounted for 43.4% of the administered ethanol-labeled compound and 44.9% of the ethoxy-labeled compound. The second most abundant, metabolite G, amounted to 32.1% of the administered ethanol-labeled compound and 28.0% for the ethoxy-labeled compound. The remaining eight radioactive components accounted for less than 3% of the administered dose. Analysis by HPLC of urine subjected to acid hydrolysis showed a disappearance of metabolite G with a concomitant increase in metabolite H, indicating the presence of a possible glycine conjugate.
Urinary metabolite H, isolated by HPLC, was further purified by fractional distillation at atmospheric pressure to yield a colorless liquid, boiling at 207°C. This metabolite was subsequently identified as ethoxyacetic acid by comparison of boiling points, GLC retention times on two different columns, and TLC Rf values with those of the authentic reference compound. The identification of this compound was confirmed by mass spectral analysis (Fig. 3) .
Urinary metabolite G did not elute from the gas chromatographic column under the conditions used. Subsequently, the ethyl ester of this metabolite was formed and isolated by fractional distillation at reduced pressure to yield a colorless liquid boiling at 107.5°C/0.01 mm Hg. This metabolite was further identified as N-ethoxyacetyl glycine by comparison of boiling points, GLC retention times on two different columns, and TLC Rf values of its ethyl ester with those of the authentic compound (Table 3) .
Minor metabolites in the urine, accounting for only 3 to 5% of the administered 14C, were not identified. However, their failure to respond to conditions of hydrolysis or esterifiction indicates that these metabolites were not amino acid or glucuronic acid conjugates.
Identification of Metabolites Isolated from Testes
Analysis of extracts of rat testes by HPLC indicated that the amount of 14C in the testes peaked at 2 hr after administration of the ethanol-labeled compound and 
Discussion
The results of this study indicate that metabolism of 2-ethoxyethanol in the rat proceeds primarily through oxidation to the corresponding acid, with some subsequent conjugation of the acid metabolite with glycine. These results confirm the work of Jonsson et al. (15) and are consistent with the biotransformation pathways reported for other ethylene glycol monoalkyl ethers (11) (12) (13) (14) . In the present study, the principal difference observed in the metabolic profiles of the two different labeled 2-ethoxyethanols was in the higher amount of expired 14CO2 from the ethoxy-labeled compound with a concomitant shortening of the biological half-time. After administration of radiolabeled 2-ethoxyethanol, a single metabolite, ethoxyacetic acid, was identified in the rat testes.
Although the metabolism of 2-ethoxyethanol has been studied to some extent, information pertaining to its quantitative metabolism and excretion has not been previously reported. After incubation of2-ethoxyethanol with Acetobacter suboxidans, Hrotmatka and Polesofsky (24) and man (25, 26) . In the present study, cleavage of the ethoxy-labeled compound resulted in the elimination of 11.7% of the dose as 14CO2.
However, only 4.6% of the administered ethanol-labeled compound was eliminated as 14CO2. These results show that the ether linkage of 2-ethoxyethanol was cleaved to the extent of at least 11.7% in the rat. Although testicular damage has been reported in the rat following administration of certain of the ethylene glycol monoalkyl ethers (7, 9) , accumulation of the compounds or their metabolites in the testes does not appear likely. Miller et al. (10) , studying radiolabeled 2-methoxyethanol, found only 0.13% of the orally administered 14C in the testes after 48 hr. In addition, these investigators noted that the amount of 14C in the testes was low in comparison with that in the blood, indicating a lack of accumulation. In the present study, the level of 14C in the testes was highest at 2 hr after the administration of 2-ethoxyethanol [ethanol-1,2-14C] and decreased rapidly thereafter. The only radioactive compound detected in that tissue was ethoxyacetic acid. These results are consistent with the findings of Miller et al. (11) for methoxyacetic acid and suggest that the acid metabolites may be the activating agents for the testicular changes resulting from exposure to the ethylene glycol monoalkyl ethers.
Mention of company or product names is not to be considered an endorsement by the National Institute for Occupational Safety and Health.
